octobre 28, 2025 - octobre 29, 2025
Connect with as at the 24th Annual Market Access Summit
Delta Hotels Toronto | 75 Lower Simcoe Street, Toronto, ON M5J 3A6
11:50 AM Tuesday, October 28
Panel Discussion
The Canadian market access landscape is rapidly evolving due to shifting government policies, payer dynamics, and the complexity of biopharmaceutical innovation. This session will explore key trends, including pricing and policy changes, data-driven decision-making, new funding models, equity in access and digital health solutions, while highlighting opportunities for industry stakeholder collaboration to enhance patient access.
- Impact of Pricing and Policy Changes within Canada/US, Globally
- Navigating evidence demands for high-cost therapies and rare disease treatments, leveraging real-world evidence, health outcomes data, and patient-reported outcomes to meet payer evidence demands
- Data-Driven Decision Making and the growing importance of economic modeling and burden-of-illness studies
- Equity of access and digital health solutions and value-based reimbursement models exploring opportunities for collaboration between industry stakeholders to improve patient access
Collette Williams
Senior Director, Strategic Consulting
Recognized for her strategic vision and ability to foster strong stakeholder engagement, Collette leads a high-performing team at Innomar Strategies-Cencora. Under her leadership, the team provides clients with innovative solutions to ensure successful product launches and sustained market access, ultimately driving meaningful advancements in patient care on a global scale.
Increase market access in specialty care
Our breadth of industry experience, expertise in specialty, and tailored solutions will ensure patients have timely access to your specialty medication when they need it the most.
InnomarConsulting™ services include
- Market research and landscape assessment requirements
- Expertise in numerous complex therapeutic areas including rare disease, oncology, and immunology
- Pricing strategy, pCPA negotiations and product listing agreements (PLAs) for optimal success
- Health economic modeling
Who to meet with
Advisory boards comprised of payers, leading physicians and other key opinion leaders
Consultation with patient associations and advocacy groups in Canada
Preparatory meetings with review bodies and key clinicians as needed
Let's Connect
Fill out the form below to request a time to connect with our experts while attending the 24th Annual Market Access Summit or if you are interested to learn how our expert insights can guide your business decisions.
